1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

Similar documents
Plasma lipoproteins & atherosclerosis by. Prof.Dr. Maha M. Sallam

Pathophysiology of Lipid Disorders

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry


Lipid/Lipoprotein Structure and Metabolism (Overview)

Arteriosclerosis & Atherosclerosis

Lipids digestion and absorption, Biochemistry II

High density lipoprotein metabolism

ANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism


Lipoproteins Metabolism

Chapter VIII: Dr. Sameh Sarray Hlaoui

THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS


Lipoprotein Particle Profile

CHAPTER FORTY FIVE ENDOGENOUS LIPID TRANSPORT PATHWAY: VLDL AND IDL

Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD

Nutrition, Food, and Fitness. Chapter 6 Fats: A Concentrated Energy Source

Cholesterol metabolism. Function Biosynthesis Transport in the organism Hypercholesterolemia

Normal blood vessels A= artery V= vein

Lipid metabolism in familial hypercholesterolemia

Nutrition & Wellness for Life 2012 Chapter 6: Fats: A Concentrated Energy Source

Chapter (5) Etiology of Low HDL- Cholesterol

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers

Cholesterol and its transport. Alice Skoumalová

Metabolic defects underlying dyslipidemia in abdominal obesity

LIPID METABOLISM. Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI

ATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS

Hypertriglyceridemia: Why, When, and How to Treat. Gregory Cohn, MD, FNLA, FASPC

Hyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi

PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL

Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID?

Prof. John Chapman, MD, PhD, DSc

Disclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017

Chapter 18. Diet and Health

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

Dyslipidemia Endothelial dysfunction Free radicals Immunologic

Cholesterol Metabolism

N-3 Fatty Acids Non-HDL-Cand LDL-C Thomas Dayspring MD, FACP

Hypertriglyceridemia. Ara Metjian, M.D. Resident s Report 20 December 2002

Incorporating HDL interaction in an ODE model of Atherosclerosis

Lipids Definition. Definition: Water insoluble No common structure (though generally large R groups)

Definition: Water insoluble No common structure (though generally large R groups)

determination of Triglyceride in Serum Amal Alamri

PPAR history of research

BIOB111_CHBIO - Tutorial activity for Session 12

HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME

Lipid Metabolism. Remember fats?? Triacylglycerols - major form of energy storage in animals

Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice

General pathophysiology LIPID METABOLISM

STRUCTURE AND METABOLISM Of LIPIDS AND LIPOPROTEINS. R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty

CHM333 LECTURE 34: 11/30 12/2/09 FALL 2009 Professor Christine Hrycyna

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:

Maintain Cholesterol

Health and Disease of the Cardiovascular system

METABOLISM of ADIPOSE TISSUE

History. Aron first proposed that fat may be essential for normal growth Tested on animals-vitamins A,D,E added. Fat deficiency severely affected

Summary and concluding remarks

Lipid Metabolism Prof. Dr. rer physiol. Dr.h.c. Ulrike Beisiegel

Fats, Cholesterol, and Hormones

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL

Topic 11. Coronary Artery Disease

Metabolic Syndrome.

Biochem. q1) the amount of cholesterol lost per day is: +a.1g/day b.10g/week c.15g/day d.5g/day

Cellular control of cholesterol. Peter Takizawa Department of Cell Biology

1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver)

LIPIDS Dr. Latifah Al-Oboudi 2012

Nature Genetics: doi: /ng.3561

Digestion and transport of TAG by plasma lipoproteins

Inspired Functional Ingredients to Innovate and Differentiate Your Brand. Products by Ecovatec Solutions Inc.

5. THE ROLE OF LIPIDS IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE: GUIDELINES FOR DIAGNOSIS AND TREATMENT

Lipoprotein Pathophysiology. Lipoprotein Pathophysiology

MMBS, MMED (Path),MAACB, MACTM, MACRRM

Tracking a Killer Molecule

Chemistry Chapter 21

CHAPTER 28 LIPIDS SOLUTIONS TO REVIEW QUESTIONS

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

BIOL2171 ANU TCA CYCLE

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants

Moh Tarek + Suhayb. Tamara Al-Azzeh + Asmaa Aljeelani ... Faisal

Lipids, lipoproteins and cardiovascular disease

CHAPTER 28 LIPIDS SOLUTIONS TO REVIEW QUESTIONS

Lipids: Fats, Oils & Waxes: AP Biology

LIPIDS OF PHYSIOLOGICAL SIGNIFICANCE

Regulating Hepatic Cellular Cholesterol

ATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber

Dr G R Letchuman. Clogged by Cholesterol

Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins

An educational booklet for patients with familial hypercholesterolemia DR. LEIV OSE

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

Adipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

QUESTIONS ANSWERED BY

DYSLIPIDEMIA PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

7 ANIMALS Blood Vessels.notebook. January 11, Human Blood Vessels

Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine

Transcription:

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien molecules contain? 6 VLDL is secrete by? 7 Delivers triglycerides from liver to? 8 Cellular uptake of LDL requires LDL receptors. LDL receptors recognize the apo protein. 9 In the presence of an accumulation of these cells, a linear will become visible on the inside of the artery, bulging into the lumen. 10 The macrophages uptake only oxidized lipids through the receptor. Lipids are oxidized by. Therefore may help protect from the development of atherosclerosis. Hybrphocitiy 2 albumin 3-chylomicrons 4 lipoproteins 5-1) contain phospholipids, cholesterol, and apoproteins 2) triacylglycerols and cholesterol esters in the inside 6Liver 7tissues 8apoB-100 (bind LDL receptor). 9 fatty streak 10 SR-A1 free radicals antioxidants 75

11. In atherosclerosis the cells at the centre of the plaque are a. Macrophages b. Foam cells c. Leukocytes d. Smooth muscle cells e.? 12. All of the following are major risk factors for atherosclerosis EXCEPT: a Obesity b. Hyperlipidaemia c. Smoking d. Hypertension e. Diabetes 15 Which of the following statements about circulating lipoproteins is correct? 13 Atherosclerosis a. Is initiated by endothelial injury b. Is a disease of the media of blood vessels c. Predominantly involves arterioles d. Is most common in the internal carotid arteries e. Begins in middle age 14. Regarding atherosclerosis a. The risk is directly related to HDL (high density lipoprotein) levels B It typically beings in childhood, but only manifests itself in later life c. It involves smaller elastic and larger muscular arteries d. 20% of all deaths in USA are attributable to this disease process a) Chylomicrons release cholesterol to adipose tissues. b) VLDL release cholesterol to the liver. c) chylomicrons contain mainly dietary triacylglycerols in their core. d) LDL contain mainly dietary triacylglycerols in their core.

L 8 Abnormalities of lipid metabolism Clinical chemistry 10-12-2017

1

Small oxidized LDL Plaque formation

Oxidized LDL and atherosclerosis 3

Plaques consist of : -cholesterol, -oxidized lipids, -inflammatory cells such as neutrophils and macrophages, which accumulate under the endothelial lining of the artery and extend into the arterial wall.

atherogenic lipid profile: LDL (esp. small, dense, oxidised) apob (= reflect better LDL particle number than conc. of LDL) HDL apo(a) TAG (if accompanied by FFA) ƒtag contribute to the formation of small dense LDL

small dense LDL particles damage arteries because: 1- the particles stay longer in the blood and are damaged by oxidation 2-the altered and smaller particles are taken up by scavenger receptors in the lining of blood vessels and form atheromas. Atheroma Jfi

Classification of lipid disorders A-Fredrickson classification JFI -genetic rare disorders -according to Fredrickson classification, the disorders are mainly 6 types, Familial combined hyperlipidaemia is most common type caused by an overproduction of VLDL, which is the precursor of LDL, resulting in rise of TG AND CHOLESTROL levels. Xanthoma fat deposits full of lipids 5

Classification of lipid disorders B-Secondary lipid disorders *Are those arising as a consequence of a disease( hypothyroidism),drug treatment, defective nutrition Mixed dyslipidemia : mainly caused by excessive intake of FFA from food ( fat, carbohydrates). The FFA are delivered to the liver, causing increased production of VLDL. Obesity : results from dysfunctional fat metabolism or increased fat intke, FFA are delivered to the liver, causing increased production of VLDL. Alcohol consumption promotes overproduction of FA s, increasing VLDL. A major mechanism for overproduction of VLDL is insulin resistance, because insulin normally suppress the release of FA from adipose stores. resistance of the adipocytes to insulin causes excessive release of FAs with hepatic overproduction of VLDL. Drugs used to treat AIDS damage fat cells causing insulin resistance 6

Q) serum sample from a patient had a milky appearance and produced very high TG content. A-What lipoprotein is causing this? B-And what is the clinical significance of this test result? A-VLDL particles and chylomicrons. (b) When TAG concentrations are more than 10 mmol/l, chylomicrons are present. high chylomicrons (Very high TAGs) can cause inflammation of the pancreas. The best treatment is a low fat diet but drugs may also be necessary. Lipemic serum 7